Lesson 7.2: Biostatistics and Epidemiology

Introduction

In this lesson, we will explore the foundational principles of biostatistics and epidemiology, which are essential for understanding health trends and making informed medical decisions. We will cover study designs, the impact of bias in research, and how to measure association and effect in populations. Additionally, we will delve into the characteristics of diagnostic tests and their predictive values. By the end of this lesson, students will be able to interpret different study designs, calculate and apply sensitivity, specificity, and understand key concepts such as incidence, prevalence, and screening.

Learning Objectives

Understand study design, bias, and measures of association and effect.
Grasp diagnostic test characteristics and predictive values.
Define incidence, prevalence, screening, and population-health concepts.
Interpret study designs and statistical measures.
Calculate and apply sensitivity, specificity, and predictive values.

Section 1: Study Design

Study design is a critical component of research that serves as the blueprint for collecting, measuring, and analyzing data. The appropriate study design depends on the research question and hypothesis. Here are the major types of study designs:

1.1 Observational Studies

In observational studies, researchers observe phenomena without intervening. The main types are:

Cohort Studies: Follow a group over time to see who develops the outcome.
Case-Control Studies: Compare individuals with a specific condition to those without it.
Cross-Sectional Studies: Assess a population at a single point in time.

Example: Cohort Study

Consider a cohort study investigating the association between smoking and lung cancer. Researchers select two groups: smokers and non-smokers, and follow them for several years to see how many individuals from each group develop lung cancer. The relative risk (RR) can be calculated as follows:

o Identifying smokers and non-smokers provides data on disease occurrence related to smoking.

$$\text{RR} = \frac{P(Disease|Exposed)}{P(Disease|Not \ Exposed)}$$

1.2 Experimental Studies

Experimental studies involve the manipulation of variables to observe outcomes and usually involve a control group. The most common type is the randomized controlled trial (RCT).

Example: Randomized Controlled Trial

In a clinical trial testing a new medication, participants are randomly assigned to receive either the drug or a placebo. For instance, if 100 participants receiving the drug experience improvement compared to only 50 in the placebo group:

$$\text{Relative Risk (RR)} = \frac{50 / 100}{50 / 100} = 1$$

1.3 Bias in Study Design

Bias refers to systematic errors in the design, conduct, or analysis of research that can lead to incorrect conclusions. Common types of bias include:

Selection Bias: When participants selected for a study are not representative of the general population.
Information Bias: Occurs when there are systematic differences in how data on exposure or outcome is collected.

Understanding and minimizing bias is crucial for maintaining the validity of the study’s conclusions.

Section 2: Measures of Association and Effect

Once studies are conducted, researchers need to quantify the relationship between exposure and outcomes. Two key measures are:

Odds Ratio (OR): Provides the odds of an outcome occurring in the exposed group versus the unexposed group.
Relative Risk (RR): Indicates the likelihood of developing the outcome in the exposed group compared to the unexposed group. These measures help in establishing causative relationships.

2.1 Odds Ratio Calculation

Using the previous example of a cohort study:

Assume:

Number of lung cancer cases in smokers (A) = 100
Number of lung cancer cases in non-smokers (B) = 50

$- Total smokers (C) = 200$

$- Total non-smokers (D) = 200$

The Odds Ratio can be calculated as:

$$\text{OR} = \frac{A/C}{B/D} = \frac{100/200}{50/200} = 2$$

This suggests smokers have double the odds of developing lung cancer compared to non-smokers.

Section 3: Diagnostic Test Characteristics

Understanding diagnostic tests is critical in clinical decision-making. Key characteristics include sensitivity, specificity, and predictive values.

3.1 Sensitivity and Specificity

Sensitivity: The proportion of true positives that are correctly identified by the test. It is calculated as:

$$\text{Sensitivity} = \frac{True \ Positives}{True \ Positives + False \ Negatives}$$

Specificity: The proportion of true negatives correctly identified. It is calculated as:

$$\text{Specificity} = \frac{True \ Negatives}{True \ Negatives + False \ Positives}$$

3.2 Predictive Values

Positive Predictive Value (PPV): Probability that subjects with a positive screening test truly have the disease. It is given by:

$$\text{PPV} = \frac{True \ Positives}{True \ Positives + False \ Positives}$$

Negative Predictive Value (NPV): Probability that subjects with a negative screening test truly do not have the disease. It is given by:

$$\text{NPV} = \frac{True \ Negatives}{True \ Negatives + False \ Negatives}$$

Example Calculation: Sensitivity and Specificity

Imagine a screening test for a disease where:

$- True Positives = 80$

$- False Negatives = 20$

$- True Negatives = 50$

$- False Positives = 10$

Calculating sensitivity:

$$\text{Sensitivity} = \frac{80}{80 + 20} = 0.80$$

Calculating specificity:

$$\text{Specificity} = \frac{50}{50 + 10} = 0.833$$

Section 4: Incidence, Prevalence, and Screening

4.1 Incidence

Incidence is a measure of the occurrence of new cases of disease in a population during a specified time period. It is calculated as:

$$\text{Incidence} = \frac{Number \ of \ New \ Cases}{Total \ Population} \times 1000$$

4.2 Prevalence

Prevalence reflects the total number of cases, both new and existing, in a population at a given time, calculated as:

$$\text{Prevalence} = \frac{Total \ Cases}{Total \ Population} \times 100$$

4.3 Screening and Population Health Concepts

Screening aims to identify undiagnosed diseases in asymptomatic populations. It is crucial that screening tests have high sensitivity and specificity to reduce false positives and negatives, ensuring better overall public health.

Conclusion

In summary, biostatistics and epidemiology are vital for understanding the health of populations. By mastering these concepts, students will be better equipped to understand research studies, assess the effectiveness of interventions, and apply this knowledge in clinical settings. Moving forward, it is essential to recognize the impact of biases in research and the importance of diagnostic test characteristics in patient care.

Study Notes

Study designs include observational (cohort, case-control, cross-sectional) and experimental (RCT).
Bias affects study validity; common biases are selection and information bias.
Measures of association: Odds Ratio (OR) and Relative Risk (RR).
Diagnostic test characteristics: Sensitivity, Specificity, PPV, NPV.
Incidence and prevalence are key population health measures; screening is vital for early disease detection.